Advances in Drug Research: v.30
Published on 22. August 1997
Book
Hardback
352 pages
978-0-12-013330-7 (ISBN)
Description
This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets. It will be the last volume edited by Bernard Testa and Urs A. Meyer.
This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets. It will be the last volume edited by Bernard Testa and Urs A. Meyer.
This volume continues the trend for Advances in Drug Research of shorter, but more frequent volumes. In line with the tradition of the series, chapters on general themes are interspersed with chapters on specific drug classes and targets. It will be the last volume edited by Bernard Testa and Urs A. Meyer.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
College/higher education
Professional and scholarly
Illustrations
b&w illustrations
Dimensions
Height: 229 mm
Width: 152 mm
Weight
513 gr
ISBN-13
978-0-12-013330-7 (9780120133307)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Content
The concept of emergence dissolvence in drug research, B. Testa and L.B. Kier; sense and non-sense in toxicity assessment of medicinal products, A.G. Rauws, E.J. De Waal and J.W. van der Laan; the concept of chiral conformers and its significance in molecular pharmacology, M. Simonyi; combinational libraries for enhanced drug discovery, E.R. Felder and D. Poppinger; reversal of chloroquine resistance in malaria - a new concept of chemotherapy, S. Batra and A.P. Bhaduri.